Admin Core
管理核心
基本信息
- 批准号:10598935
- 负责人:
- 金额:$ 19.71万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-01 至 2028-07-31
- 项目状态:未结题
- 来源:
- 关键词:AIDS related cancerAddressAdvanced DevelopmentBehavioral SciencesBiomedical EngineeringBrazilCancer CenterCancer Research ProjectCategoriesCervical Cancer ScreeningCervical dysplasiaClinicalCollaborationsCommunicationCommunitiesCountryDataDevelopmentDiagnosisEnsureEpidemiologyExtramural ActivitiesFundingGoalsGrantHIVHIV InfectionsHIV/AIDSHealth SciencesHospitalsIndividualInfrastructureInstitutionLeadershipLifeMalignant NeoplasmsMalignant neoplasm of cervix uteriMentorsMonitorMozambiqueNational Cancer Advisory BoardNational Cancer InstitutePathologyPersonsPilot ProjectsPreventionPrevention approachRecording of previous eventsReportingResearchResearch InfrastructureResearch PersonnelResearch Project GrantsResearch TrainingResource SharingRiceRiskRisk FactorsSiteSpecimenStructureTechnologyTexasUnited States National Institutes of HealthUniversitiesVisionWomanWorkcareerco-infectioncomorbiditycostlow and middle-income countriesmeetingsnovelprogramsresearch studysuccessvirtual
项目摘要
ABSTRACT
The overall vision of the AVANÇO Research Consortium is to establish sustainable infrastructure
to develop research programs focused on HIV-associated malignancies in Brazil and
Mozambique. The research theme chosen for this U54 HIV-Associated Malignancy Research
Center (HAMRC) is to develop novel, low-cost and technologically feasible approaches for
cervical cancer screening, diagnosis, and treatment in women living with HIV (WLWH) in low- and
middle-income countries (LMICs). This HAMRC will be a collaboration between institutions in the
US, Mozambique and Brazil and includes investigators with expertise in HIV/AIDS, Cervical
Cancer, Bioengineering, Pathology, Epidemiology and Behavioral Science. The investigators
have several ongoing scientific and clinical collaborations which include projects across all three
countries.
Our proposal addresses the NIH priority: To address HIV-associated comorbidities, coinfections
and complications, which includes Malignancies as a category. HIV infection is a known risk factor
for cervical cancer, with WLWH having an approximate 6-fold increased risk of developing cervical
cancer.
The overall goals of the AVANÇO Research Consortium include:
1) Establish sustainable research infrastructure to perform multi-institutional research studies
related to HIV-associated malignancies across institutions in the US, Brazil and Mozambique. We
will build a comprehensive research program focused on identifying novel, low-cost and
technologically feasible approaches for the prevention, diagnosis, and treatment of cervical
cancer in WLWH in LMICs.
2) Conduct two Research Projects that advance the development of promising low-cost
technologies focused on the diagnoses of high-grade cervical dysplasia and invasive cervical
cancer among WLWH.
3) Facilitate and enhance the professional development of junior investigators to conduct HIV-
associated malignancy research in Mozambique and Brazil. Through our Developmental Core
and Shared Resource Core, we will build research capacity and collaboration through formal
research training courses, pilot project funding, and implementation of a Project ECHO® program
for research capacity building focused on mentoring and supporting early-career investigators.
摘要
安凡尼欧研究联盟的总体愿景是建立可持续的基础设施
在巴西开展以艾滋病毒相关恶性肿瘤为重点的研究项目,
莫桑比克.本次U 54艾滋病相关研究选择的研究主题
该中心(HAMRC)的目标是开发新的,低成本和技术可行的方法,
在低收入和低收入妇女中进行宫颈癌筛查、诊断和治疗
中等收入国家(LMIC)。该人权高专办将是一个机构之间的合作,
美国、莫桑比克和巴西,包括具有艾滋病毒/艾滋病、宫颈癌和生殖器疾病方面专业知识的研究人员。
癌症、生物工程、病理学、流行病学和行为科学。调查人员
有几个正在进行的科学和临床合作,其中包括所有三个项目
国家
我们的提案涉及NIH的优先事项:解决HIV相关的合并症,合并感染
和并发症,其中包括恶性肿瘤作为一个类别。艾滋病毒感染是一个已知的风险因素
对于宫颈癌,WLWH的宫颈癌发生风险增加约6倍,
癌
AVANESTO研究联盟的总体目标包括:
1)建立可持续的研究基础设施,以进行多机构研究
在美国、巴西和莫桑比克的机构中,我们
将建立一个全面的研究计划,重点是确定新的,低成本的,
预防、诊断和治疗宫颈癌的技术可行方法
低收入国家的WLWH癌症。
2)开展两个研究项目,推动有前途的低成本
专注于诊断高度宫颈发育不良和侵袭性宫颈的技术
WLWH中的癌症
3)促进和加强初级调查人员的专业发展,
在莫桑比克和巴西进行的相关恶性肿瘤研究。通过我们的发展核心
和共享资源核心,我们将建立研究能力和合作,通过正式的
研究培训课程,试点项目资金,以及ECHO®项目的实施
在研究能力建设方面,侧重于指导和支持早期职业调查人员。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kathleen Schmeler其他文献
Kathleen Schmeler的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kathleen Schmeler', 18)}}的其他基金
A Randomized Clinical Trial to Assess the Effectiveness of Ablative Treatments for Cervical Cancer Risk Reduction in HIV+ Women living in Mozambique
一项随机临床试验,旨在评估消融治疗对莫桑比克艾滋病毒妇女降低宫颈癌风险的有效性
- 批准号:
10430798 - 财政年份:2020
- 资助金额:
$ 19.71万 - 项目类别:
A Randomized Clinical Trial to Assess the Effectiveness of Ablative Treatments for Cervical Cancer Risk Reduction in HIV+ Women living in Mozambique
一项随机临床试验,旨在评估消融治疗对莫桑比克艾滋病毒妇女降低宫颈癌风险的有效性
- 批准号:
10490357 - 财政年份:2020
- 资助金额:
$ 19.71万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 19.71万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 19.71万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 19.71万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 19.71万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 19.71万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 19.71万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 19.71万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 19.71万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 19.71万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 19.71万 - 项目类别:
Research Grant